Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in the United States, 5 Horizons Capital is a venture capital organization focused on supporting clinical-stage biotechnology companies. Operating as a Venture Capital-as-a-Service (VCaaS) platform, it combines capital with advisory services and partnerships with Contract Research Organizations (CROs). This approach facilitates clinical progress for its portfolio companies.
5 Horizons Capital invests in clinical-stage biotechnology companies, providing comprehensive diligence across scientific, clinical, operational, and financial aspects. They align capital deployment with CRO milestones and trial progression, emphasizing capital efficiency and institutional-grade investment materials. Their goal is to accelerate the path from discovery to clinical trials.
5 Horizons Capital has collaborated with notable biotech companies such as Piston Bio, which received a comprehensive evaluation and venture investment report, and Higher Medicine, which secured seed funding along with operational support through CRO connections. Additionally, Kadence Bio benefited from reduced clinical trial costs by aligning incentives with an Australian CRO.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.